A multinational pharmaceutical organisation with a workforce of approximately 46,000 and operations spanning the United States, Europe, and the Middle East sought to realign leadership priorities, organisational capability, and operating model design in the face of rapid innovation demands, regulatory complexity, and competitive pressures.
The organisation was pursuing simultaneous strategic objectives: accelerated R&D productivity, improved cross-functional integration between commercial and regulatory units, and enhanced executive coherence on enterprise-wide transformation initiatives. These ambitions placed elevated scrutiny on governance effectiveness, leadership clarity, and accountability around performance outcomes.
The CEO and Executive Committee engaged strategic advisory to:
The engagement proceeded through three phases:
Comprehensive assessment of leadership capability, organisational structures, and critical capability gaps was conducted across all major functions and regions.
Co-creation of a future-ready operating model, clarifying roles, decision rights, escalation protocols, and cross-functional interfaces, aligned to strategic priorities and regulatory imperatives.
Facilitated executive workshops and governance sessions to embed agreed priorities, reinforce performance accountability, and support transition planning for critical leadership pathways.
These outcomes reflect aggregate performance impacts across the engagement's 12-month span:
The engagement reinforced the organisation's capacity to:
Senior transformation and governance advisor to the CEO and Executive Committee, working closely with the Chief Operating Officer, Head of Global Strategy, and Board Governance Committee.
Strategic advisory to a 14,500-person GCC retail & investment bank — board governance, leadership continuity, and AI/transformation oversight across the UAE and wider Gulf.
Read case study
Strategic advisory to a 72,000-person global technology enterprise — AI integration, governance, and a workforce transformation blueprint built to withstand regulator and stakeholder scrutiny.
Read case studyFor Board Advisory, Strategic Consulting, Keynote Speaking or Private Executive Advisory enquiries, please write with a short note on the decision, audience or transformation context. Suitable engagements are shaped through an initial private conversation.